medigraphic.com
ISSN 2992-8559 (Digital)
ISSN 1405-0625 (Impreso)

2010, Número 3

<< Anterior Siguiente >>

Cir Plast 2010; 20 (3)


Enfermedad por la infiltración de sustancias modelantes con fines estético

Torres GB, Medrano RG, Priego BRB, Peláez BI, Burgos VR

Idioma: Español
Referencias bibliográficas: 50
Paginas: 124-132
Archivo PDF: 365.35 Kb.


RESUMEN

El deseo de cumplir con ciertos patrones de belleza ha propiciado la infiltración de sustancias con fines modelantes. Se describen los síntomas y la patología relacionados con la infiltración de sustancias modelantes en una serie de casos consecutivos atendidos en forma multidisciplinaria en el Hospital General de México, de enero de 1999 a octubre de 2009. Se incluyeron 279 pacientes: 234 mujeres y 45 hombres, de 21 a 81 años de edad, quienes se infiltraron aceite mineral, guayacol, silicón, aceite vegetal, aceite de automóvil, grasa bovina, y vitaminas. La cantidad infiltrada de estas sustancias fue de 10 mL a 10 litros. Los sitios infiltrados fueron: glúteos, mamas, piernas, muslos, caderas, cara y otros. La aparición de sintomatología se observó desde el primer mes hasta 18 años después de la infiltración de las sustancias. Las manifestaciones locales fueron hiperemia, dolor, nódulos, engrosamiento de la piel y de tejido subcutáneo, hiperpigmentación, neoformaciones venosas, migración de la sustancia infiltrada y otras. Los síntomas sistémicos fueron fiebre, artralgias y mialgias, entre otros. El 14.2% desarrolló enfermedades del tejido conectivo. Aunque su verdadera prevalencia e incidencia son desconocidas, representa actualmente un serio problema de salud pública en países como México.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Miyoshi K, Miyaoka T, Kobayashi Y, Itahura T, Nishijo K, Higashitara M, Shiragami H, Ohno F: Hypergammaglobulinemia by prolonged adjuvancy in man: disorder developed. After augmentation mammoplasty. Ijishimpo 1964; 2122: 9-14.

  2. Edelman D, Grant S, Van Os W. Autoimmune disease following the use of silicone gel-filled breast implant: A review of the clinical literature. Sem in Arthritis and Rheum 1994; 24: 183-189.

  3. Yumagai Y, Shiokawa Y, Medsger T, Rodnan G. Clinical spectrum of the conective tissue disease after cosmetic surgery. Arthritis and Rheum 1984; 27: 1-12.

  4. Fock K, Feng PH, Tey BH. Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol 1984; 11: 98-100.

  5. Appleton B, Lee P. The development of systemic sclerosis (Scleroderma) following augmentation mammoplasty. J Rheumatol 1993; 20: 1052-4.

  6. Rae Y, Pardo R, Blackwelder P. Leg ulcers following subcutaneous injections of a liquid silicone preparation. Arch Dermatol 1989; 125: 670-673.

  7. Wilkie T. Late development of granuloma after liquid silicone injections. Plast and Reconstr Surg 1977; 60: 179-188.

  8. Chastre J, Bouchama A, Basset F. Acute pneumonitis after subcutaneous injections of silicone in transsexual men. N Engl J Med 1983; 308: 764-767.

  9. Kircher T. Silicone lymphadenopathy. Hum Pathol 1980; 11: 240-244.

  10. Brozena S, Fenske N, Cruse W, Espinosa C et al. Human adjuvant disease following augmentation mammoplasty. Arch Dermatol 1988; 124: 1383-1386.

  11. Boo-Chal K. Parafinoma. Plast Reconstr Surg 1965; 36: 101-110.

  12. Adler A, Etzion Z, Berlyne G. Uptake, distribution and excretion of silicone in normal rats. Am Phys Soc 1986: E670-E673.

  13. Menezes RC, Tiziani V, Cintra L, Amstalden I, Badan PF. Local reaction and migration of injected silicone gel: Experimental study. Aesthetic Plast Surg 1993; 17: 335-338.

  14. McDowell F. Complications with silicones – what grade of silicones how do we know in was silicones. Plast Reconstr Surg 1978; 61: 892-895.

  15. Sánchez-Guerrero J, Schur P, Sergent J, Liang M. Silicone breast implants and rheumatic disease. Arthritis and Rheum 1994; 37: 158-168.

  16. Pietra G, Jiménez S, Daniele R. Experimental silicosis. Am Assoc Pathol 1980; 101: 595-607.

  17. Spiera R, Gibofsky A, Spiera H. Silicone gel filled breast implant and connective tissue disease: an overview. J Rheumatol 1994; 21: 239-45.

  18. Vasey F, Selenik M, Wells A. Rheumatic disease symptoms and silicone breast implants: comment on the article by Cook et al and the article by Sánchez-Guerrero et al. Arthritis and Rheum 1995; 38: 719-720.

  19. Rees T, Ballantyne D, Seidman I, Hawthorne G. Visceral response to subcutaneous and intraperitoneal injections of silicone in mice. Plast Reconstr Surg 1967; 39: 402-10.

  20. Cook R, Harrison M, LeVier R. The breast implants controversy. Arthritis and Rheum 1994; 2: 153-57.

  21. Cukier J, Beauchamp R, Spindler J, Spindler S, Lorenzo C, Trentham D. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 1993; 118: 920-928.

  22. Travis W, Balagh K, Abraham J. Silicone granulomas: report of three cases and review of the literature. Hum Pathol 1985; 16: 19-27.

  23. Blocksma R, Braley S. The silicones in plastic surgery. Plast Reconstr Surg 1965; 35: 366-370.

  24. Scheel L, Riper J. Toxicity of silica. Archives of Industrial Hygiene and Occupational Medicine 1954; 9: 29-36.

  25. Rees T, Platt J, Ballantyne D. An investigation of cutaneous response to dimethyl polysiloxane (silicone liquid) in animals and humans – a preliminary report. Plast Reconstr Surg 1965; 35: 131-139.

  26. Carter D. Editorial tissue reaction to breast implants. Am J Clin Pathol 1994: 565-566.

  27. Byrd W, Nunley J. Bilateral silicone induced synovitis of the wrist. J Rheumatol 1987; 14; 1202-1205.

  28. Ben-Hur N, Ballantyne D, Rees T, Seidman I. Local and systemic effect of dimethylpolysiloxane fluid in mice. Plast Reconstr Surg 1967; 39: 423-426.

  29. Wustrack K, Zarem H. Surgical management of silicone mastitis. Plast Reconstr Surg 1979; 63: 224-229.

  30. Pearl R, Laub D, Kaplan E. Complications following silicone injection for augmentation of the contours of the face. Plast Reconstr Surg 1978; 61: 888-891.

  31. Worsing R, Engber W, Lange T, Wisconsin M. Reactive synovitis from particulate silastic. J Bone Joint Surg 1982; 64: 581-585.

  32. Wagner H, Beller F, Pfautsch M. Electron and light microscopy examination of capsules around breast implant. Plast Reconstr Surg 1977; 60: 49-55.

  33. Ashley F, Braley S, Rees T et al.The present status of silicone fluid in soft tissue augmentation. Plast Reconstr Surg 1967; 39: 411-420.

  34. Ballantyne D, Rees T, Seidman MD. Response to massive subcutaneous injections of dimethylpolysiloxane fluid in animals. Plast Reconstr Surg 1965; 36: 330-338.

  35. Ortiz-Monasterio F, Trigos I. Management of patients with complications from injections of foreign material in to the breast. Plast Reconstr Surg 1972; 50: 42-47.

  36. Zúñiga MA, Carrillo-Jiménez G, Fos PJ, Gandek B, Medina-Moreno MP. Evaluación del estado de salud con la Encuesta SF-36. Salud Publica Mex 1999; 41: 110-118.

  37. Ellenbogen R, Rubin L. Injectable fluid silicone therapy. Human Morbidity and mortality. JAMA 1975; 234(3): 308-309.

  38. Travis WD, Balogh K, Abrahamn JL. Silicone granulomas: report of three cases and review of the literature Hum Pathol 1985 (1); 16: 19-27.

  39. Fisher JC. The silicone controversy-when will science prevail? N Engl J Med 1992,18; 326(25): 1696-1698.

  40. Thomassen RW, Howbert JP, Winn DF Jr, Thompson SW. The occurrence and characterization of emboli associated with the use of a silicone antifoaming agent. J Thorac Cardiovasc Surg 1961; 41: 611.

  41. Christie AJ, Weinberger KA, Dietrich M. Silicone lymphadenopathy and synovitis. Complications of silicone finger joint prostheses JAMA 1977; 237: 1463.

  42. Leong AS, Disney AP, Gove DW. Refractile particles in liver of haemodialysis patients. Lancet 1981; (8225): 889-90.

  43. Bommer J, Ritz E, Waldherr R, Gastner M. Silicone cell inclusions causing multi-organ foreign body reaction in dialyzed patients. Lancet 1981; 1(8233): 1314.

  44. Leong AS, Disney AP, Gove DW. Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis. N Engl J Med 1982; 306: 135-40.

  45. Rees TD, Platt J, Ballantyne DL Jr. An investigation of cutaneous response to dimethylpolsiloxane (silicone liquid) in animals and humans-a preliminary report. Plast Reconstr Surg 1965; 35: 131-140.

  46. Ballantyne DJ Jr, Rees TD, Seidman I. Silicone fluid: response to massive subcutaneous injections of dimethylpolysiloxane fluid in animals. Plast Reconstr Surg 1965; 36: 330-338.

  47. Ashley FL, Braley S, Rees TD, Goulian D, Ballantyne DL Jr. The present status of silicone fluid in soft tissue augmentation. Plast Reconstr Surg 1967; 39: 411-420.

  48. Picha GJ, Goldstein JA. Analysis of the soft-tissue response to components used in the manufacture of breast implants: rat animal model. Plast Reconstr Surg 1991; 87: 490-500.

  49. Kozeny GA, Barbato AL, Bansal VK, Vertuno LL, Hano JE. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med 1984; 311: 1103-05.

  50. Brody GS, Conway DP, Deapen DM, Fisher JC, Hochberg MC, LeRoy EC, Mesdger TA Jr, Robson MC, Shon AR. Weisman Consensus statement on the relationship of breast implants to connective-tissue disorders. Plast Reconstr Surg 1992; 90: 1102-1105.




2020     |     www.medigraphic.com